Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis

References

• Gutiérrez-Fisac JL, Guallar-Castillón P, León-Muñoz LM, et al. Prevalence of general and abdominal obesity in the adult population of Spain, 2008–2010: the ENRICA study. Obes Rev. 2012;13:388–392.
   PubMed Web of Science ®Google Scholar
• Chang S-H, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–287.
   PubMed Web of Science ®Google Scholar
• Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190, 215–357, iii-iv.
   Web of Science ®Google Scholar
• Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev. 2011;12:602–621.
   PubMed Web of Science ®Google Scholar
• Christou NV. Impact of obesity and bariatric surgery on survival. World J Surg. 2009;33:2022–2027.
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–2693.
   PubMed Web of Science ®Google Scholar
• Padwal RS, Sharma AM. Treating severe obesity: morbid weights and morbid waits. Can Med Assoc J. 2009;181:777–778.
   Web of Science ®Google Scholar
• Dumon KR, Murayama KM. Bariatric surgery outcomes. Surg Clin North Am. 2011;91:1313–38,x.
   PubMed Web of Science ®Google Scholar
• Sánchez-Santos R, Sabench Pereferrer F, Estévez Fernandez S, et al. Is the morbid obesity surgery profitable in times of crisis? A cost-benefit analysis of bariatric surgery. Cir Esp. 2013;91:476–484.
   PubMed Web of Science ®Google Scholar
• Prospective Delphi Study. Social and economic costs of obesity and associated diseases (hypertension, hyperlipidemia and diabetes. Madrid: Gabinete de Estudios Sociológicos Bernard Krief; 1999.
   Google Scholar
• Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II). Obes Surg. 2009;19:1542–1549.
   PubMed Web of Science ®Google Scholar
• Castilla I, Mar J, Valcárcel-Nazco C, et al. Cost-utility analysis of gastric bypass for severely obese patients in Spain. Obes Surg. 2014;24:2061–2068.
   PubMed Web of Science ®Google Scholar
• Borisenko O, Adam D, Funch-Jensen P, et al. Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive european decision analytic model. Obes Surg. 2015;25:1559–1568.
   PubMed Web of Science ®Google Scholar
• Scandinavian Obesity Surgery Registry. Annual Report 2011; [cited 2015 Apr 20]. Available from: http://www.ucr.uu.se/soreg/component/edocman/arsrapport-soreg-2011
   Google Scholar
• Lecube A, Monereo S. RICIBA (Computerized registry of bariatric surgery), what do we know about bariatric surgery in Spain? Endocrinol Nutr. 2011;58:323–324.
   PubMedGoogle Scholar
• D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–753.
   PubMed Web of Science ®Google Scholar
• Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293–298.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481–486.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S. Roux-en-Y gastric bypass vs intensive medical management for the control of Type 2 diabetes hypertension and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013 Jun 5;309:2240–2249.
   PubMed Web of Science ®Google Scholar
• National Statistics Institute (INE). Demographic phenomena. Minist. Sanidad, Política Soc. e Igual; 2017 [cited 2017 Jun 7]. Available from: www.ine.es
   Google Scholar
• Ackroyd R, Mouiel J, Chevallier JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16:1488–1503.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Slejko JF, Sculpher MJ, et al. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making. 2011;31:800–804.
   PubMed Web of Science ®Google Scholar
• Crespo C, Brosa M, Soria-Juan A, et al. Costes directos de la diabetes mellitus y de sus complicaciones en España (Estudio SECCAID: Spain estimated cost Ciberdem-Cabimer in Diabetes). Avances En Diabetología. 2013;29:182–189.
   Google Scholar
• de Andres-Nogales F, Vivancos Mora J, Barriga Hernandez FJ, et al. Use of healthcare resources and costs of acute cardioembolic stroke management in the Region of Madrid: the CODICE Study. Neurologia. 2015;30:536–544.
   PubMed Web of Science ®Google Scholar
• Lopez-Bastida J, Oliva Moreno J, Worbes Cerezo M, et al. Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain. BMC Health Serv Res. 2012;12:315.
   PubMed Web of Science ®Google Scholar
• Ray JA, Valentine WJ, Secnik K, et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Curr Med Res Opin. 2005;21:1617–1629.
   PubMed Web of Science ®Google Scholar
• Delgado JF, Oliva J, Llano M, et al. Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain. Rev Esp Cardiol (Engl Ed). 2014;67:643–650.
   PubMed Web of Science ®Google Scholar
• Schwander B, Gradl B, Zollner Y, et al. Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe–the HEALTH model. Value Health. 2009;12:857–871.
   PubMed Web of Science ®Google Scholar
• eSalud - Información económica del sector sanitario. [cited 2017 May 30]. Available from: http://esalud.oblikue.com/
   Google Scholar
• López Bastida J, Oliva J, Antoñanzas F, et al. A proposed guideline for economic evaluation of health technologies. Gac Sanit. 2010;24:154–170.
   PubMed Web of Science ®Google Scholar
• Sacristán JA, Oliva J, Llano J, et al. What is an efficient health technology in Spain? Gac Sanit. 2002;16:334–343.
   PubMedGoogle Scholar
• Consensus for the treatment of severe obesity between the Spanish Society for the Study of Obesity (SEEDO) and the Spanish Society for Obesity Surgery and Metabolic Diseases (SECO). Madrid, 20 de enero de 2016. Press releasse SECO and SEEDO; [cited 2017 Jun 1]. Available from: http://www.seedo.es/images/site/ComunicadosMedios/2016/NdP_Final_Consenso_Contra_Obesidad.pdf
   Google Scholar
• Pollock RF, Muduma G, Valentine WJ. Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK. Diabetes Obes Metab. 2013;15:121–129.
   PubMed Web of Science ®Google Scholar
• Borisenko O, Mann O, Dupree A. Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling. BMC Surg. 2017;17:87.
   PubMed Web of Science ®Google Scholar
• Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98:1422–1429.
   PubMed Web of Science ®Google Scholar
• Faria GR, Preto JR, Costa-Maia J. Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model. Obes Surg. 2013;23:460–466.
   PubMed Web of Science ®Google Scholar
• Borisenko O, Lukyanov V, Johnsen SP, et al. Cost analysis of bariatric surgery in Denmark made with a decision-analytic model. Dan Med J. 2017;64(8):A5401.
   PubMed Web of Science ®Google Scholar
• Lucchese M, Borisenko O, Mantovani LG, et al. Cost-utility analysis of bariatric surgery in Italy: results of decision-analytic modelling. Obes Facts. 2017;10:261–272.
   PubMed Web of Science ®Google Scholar
• Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med. 2011;26:1183–1194.
   PubMed Web of Science ®Google Scholar
• Lopez-de-Andres A, Jiménez-García R, Hernández-Barrera V, et al. Trends in utilization and outcomes of bariatric surgery in obese people with and without type 2 diabetes in Spain (2001–2010). Diabetes Res Clin Pract. 2013;99:300–306.
   PubMed Web of Science ®Google Scholar
• Sánchez-Santos R, Estévez S, Tomé C, et al. Training programs influence in the learning curve of laparoscopic gastric bypass for morbid obesity: a systematic review. Obes Surg. 2012;22:34–41.
   PubMed Web of Science ®Google Scholar
• Al Hajj GN, Haddad J. Preventing staple-line leak in sleeve gastrectomy: reinforcement with bovine pericardium vs. oversewing. Obes Surg. 2013;23:1915–1921.
   PubMed Web of Science ®Google Scholar
• Rubio MA, Monereo S, Lecube A. Joint position statement of the SEEN-SECO-SEEDO-SED Societies on metabolic surgery for type 2 diabetes mellitus. Endocrinol Nutr. 2013;60:547–548
   PubMedGoogle Scholar
• Buitrago F, Calvo-Hueros JI, Cañón-Barroso L, et al. Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study. Ann Fam Med. 2011;9:431–438.
   PubMed Web of Science ®Google Scholar
• Barroso LC, D’Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol CCMunity Health. 2003;57:634–638.
   PubMed Web of Science ®Google Scholar
• Barroso LC, Muro EC, Herrera ND, et al. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study. Scand J Prim Health Care. 2010;28:242–248.
   PubMed Web of Science ®Google Scholar